adalimumab,upadacitinib
abbvie
[' psa', ' ada ', 'adalimumab', 'upadacitinib', 'ada ', ' upa ']
are jaki better than tnfi in psa? abstract #0192: upadacitinib vs. adalimumab in psa using rapid3 post-hoc analysis of select-psa1 ada 40mg q14d vs. upa 15mg vs. upa 30 mg vs. placebo upa sig. improvement rapid3 vs ada from weeks 16-56 #acr22 
Rheumatologist at Duke University. Health Services Research VA fellow. Interested in reproductive rheumatology and vasculitis. Plant based ??. cas206@duke.edu.